812 related articles for article (PubMed ID: 32528662)
1. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
Baker C; Hayden MS
F1000Res; 2020; 9():281. PubMed ID: 32528662
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic applications of CRISPR RNA-guided genome editing.
Koo T; Kim JS
Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
[TBL] [Abstract][Full Text] [Related]
4. Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders.
March OP; Reichelt J; Koller U
Exp Physiol; 2018 Apr; 103(4):449-455. PubMed ID: 28271571
[TBL] [Abstract][Full Text] [Related]
5. Advances in therapeutic application of CRISPR-Cas9.
Sun J; Wang J; Zheng D; Hu X
Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
[TBL] [Abstract][Full Text] [Related]
6. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
7. Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology.
Guitart JR; Johnson JL; Chien WW
J Invest Dermatol; 2016 Sep; 136(9):e87-e93. PubMed ID: 27542298
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
9. Genome Editing: A New Horizon for Oral and Craniofacial Research.
Yu N; Yang J; Mishina Y; Giannobile WV
J Dent Res; 2019 Jan; 98(1):36-45. PubMed ID: 30354846
[TBL] [Abstract][Full Text] [Related]
10. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
11. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
Chaterji S; Ahn EH; Kim DH
Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research.
Li ZH; Wang J; Xu JP; Wang J; Yang X
Mil Med Res; 2023 Mar; 10(1):12. PubMed ID: 36895064
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
14. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
Tan JJ; Peng YZ; Huang GT
Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
Manghwar H; Lindsey K; Zhang X; Jin S
Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
[TBL] [Abstract][Full Text] [Related]
16. Research on genodermatoses using novel genome-editing tools.
Lehmann J; Seebode C; Emmert S
J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
18. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic and diagnostic relevance of Crispr technology.
El Ouar I; Djekoun A
Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
[TBL] [Abstract][Full Text] [Related]
20. Genome editing comes of age.
Kim JS
Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
